Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies.
Fargeot, Guillaume
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry 07 2020 - 786-788 p. digital
Publication Type: Letter
1468-330X
10.1136/jnnp-2020-323124 doi
Adult
Aged
Antineoplastic Agents--adverse effects
Brentuximab Vedotin--adverse effects
Female
Guillain-Barre Syndrome--chemically induced
Hodgkin Disease--drug therapy
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating--chemically induced
Young Adult
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies. [electronic resource] - Journal of neurology, neurosurgery, and psychiatry 07 2020 - 786-788 p. digital
Publication Type: Letter
1468-330X
10.1136/jnnp-2020-323124 doi
Adult
Aged
Antineoplastic Agents--adverse effects
Brentuximab Vedotin--adverse effects
Female
Guillain-Barre Syndrome--chemically induced
Hodgkin Disease--drug therapy
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating--chemically induced
Young Adult